Skip to content

Patient Preference for Biopsy Notification

Patient Preference for Biopsy Notification

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02213471
Enrollment
301
Registered
2014-08-11
Start date
2012-07-31
Completion date
2013-07-31
Last updated
2014-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elevated Risk for Melanoma

Brief summary

Effective communication between physician and patient is fundamental to effective care. The recent introduction of electronic patient on-line portals has the potential to change the communication landscape. The investigators surveyed patients to assess their preferred modality for biopsy notification at 3 institutions with differing patient access to on-line portals, to ascertain what patient preferences are currently and if it has changed from historical preferences. Our hypothesis is that as patients become more familiar with ln-line portals, their preferences will likely reflect familiarity with this modality.

Interventions

None listed

Sponsors

Maria Wei
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who were 18 years of age or older and English speaking were eligible to participate

Exclusion criteria

* Younger than 18, non-English speaking.

Design outcomes

Primary

MeasureTime frameDescription
Patient preference for biopsy notification1 yearPatients were asked to rank in order of preference their preferred method for being notified of a skin biopsy result

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026